Cargando…
Navigating the Regulatory Landscape to Develop Pediatric Oncology Drugs: Expert Opinion Recommendations
Regulatory changes have been enacted in the United States (US) and European Union (EU) to encourage the development of new treatments for pediatric cancer. Here, we review some of the factors that have hampered the development of pediatric cancer treatments and provide a comparison of the US and EU...
Autores principales: | Barry, Elly, Walsh, Jaimie A., Weinrich, Scott L., Beaupre, Darrin, Blasi, Eileen, Arenson, Daniel R., Jacobs, Ira A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8275539/ https://www.ncbi.nlm.nih.gov/pubmed/34173206 http://dx.doi.org/10.1007/s40272-021-00455-1 |
Ejemplares similares
-
Navigating adalimumab biosimilars: an expert opinion
por: Abitbol, Vered, et al.
Publicado: (2023) -
Application of Real-World Data to External Control Groups in Oncology Clinical Trial Drug Development
por: Yap, Timothy A., et al.
Publicado: (2022) -
Opinion-Based Recommendations: Beware the Tyranny of Experts
por: Spellberg, Brad, et al.
Publicado: (2021) -
Use of sexual stimuli in research and clinical settings: expert opinion and recommendations
por: Katz, Maddie A, et al.
Publicado: (2023) -
Experts Opinion
por: Goldberg, Ivan, et al.
Publicado: (2012)